| Code | CSB-RA614514MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to GSK1070806, designed for research targeting interleukin-18 (IL-18), a pro-inflammatory cytokine belonging to the IL-1 superfamily. IL-18 plays a critical role in both innate and adaptive immune responses by inducing interferon-gamma production and promoting Th1 cell differentiation. This cytokine is implicated in the pathogenesis of various inflammatory and autoimmune conditions, including rheumatoid arthritis, inflammatory bowel disease, psoriasis, and metabolic disorders such as type 2 diabetes. Elevated IL-18 levels have also been associated with cardiovascular disease and certain malignancies, making it an important target for immunological research.
GSK1070806 is a human IgG1 monoclonal antibody that specifically neutralizes IL-18 activity and has been evaluated in clinical studies for conditions including atopic dermatitis and metabolic inflammation. This biosimilar antibody provides researchers with a valuable tool for investigating IL-18-mediated signaling pathways, studying inflammatory disease mechanisms, and exploring potential therapeutic interventions targeting the IL-18/IL-18 receptor axis in preclinical models.
There are currently no reviews for this product.